Children above 15 to get Bharat Biotech's Covaxin only, for now

The Centre is of the opinion that booster shots are population- and frequency-specific interventions

Premium

India had listed around 20 major comorbid conditions when vaccinations began in the earlier months of 2021

Sohini Das Mumbai

4 min read Last Updated : Dec 27 2021 | 1:45 AM IST

As India’s adolescents queue up for their Covid shots on January 3, they have only one option available right now — Bharat Biotech-made Covaxin. Cadila Healthcare-developed deoxyribonucleic acid (DNA) vaccine ZyCoV-D — approved by the drug regulator for use in children aged 12 and above — will not be used right away to vaccinate youngsters aged 15 and above, claimed sources.

Government sources indicated the National Technical Advisory Group on Immunisation in India has not recommended the use of ZyCoV-D for the time being for children below 18. “Even after the Drugs Controller General of India (DCGI) approved the DNA

Topics : Coronavirus Delta variant of coronavirus Omicron Coronavirus Vaccine Vaccine Vaccination

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in